Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones

2025.11.26 22:18

I'm PortAI, I can summarize articles.

Bio-Techne Corp. (TECH) shares fell 1.85% to $64.63 on Wednesday, underperforming the market and competitors. The S&P 500 Index rose 0.69% and the Dow Jones Industrial Average rose 0.67%. Bio-Techne's stock ended a four-day winning streak and is 18.48% below its 52-week high. Competitors Amgen Inc. (AMGN) and Charles River Laboratories International Inc. (CRL) saw gains, while BioMarin Pharmaceutical Inc. (BMRN) also fell. Trading volume was below the 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bio-Techne Corp. (TECH) slid 1.85% to $64.63 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.69% to 6,812.61 and the Dow Jones Industrial Average rising 0.67% to 47,427.12. The stock's fall snapped a four-day winning streak. Bio-Techne Corp. closed 18.48% below its 52-week high of $79.28, which the company reached on February 5th. The stock underperformed when compared to some of its competitors Wednesday, as Amgen Inc. (AMGN) rose 1.01% to $344.57, Charles River Laboratories International Inc. (CRL) rose 0.50% to $178.94, and BioMarin Pharmaceutical Inc. (BMRN) fell 1.37% to $55.52. Trading volume (1.5 M) remained 822,025 below its 50-day average volume of 2.3 M. Data source: Dow Jones Market Data, FactSet. Data compiled November 26, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-26-25 1718ET